Phibro Animal Health Corporation (PAHC)

13.08 +0.21 (+1.63%) As of 10:54AM EDT. Market open.

Phibro Animal Health Corporation

Glenpointe Centre East
3rd Floor Suite 21 300 Frank West Burr Boulevard
Teaneck, NJ 07666-6712
United States
201 329 7300
https://www.pahc.com

Sector(s): Healthcare
Industry: Drug Manufacturers - Specialty & Generic
Full-time employees: 1,920

Key executives

Name	Title	Pay	Exercised	Year born
Mr. Jack Clifford Bendheim	Chairman, President & CEO	2.9M	N/A	1947
Mr. Larry L. Miller	Chief Operating Officer	774.91k	N/A	1964
Mr. Daniel M. Bendheim	Executive VP of Corporate Strategy & Director	548.18k	N/A	1972
Mr. Rob Aukerman	President of North America Region	619.27k	N/A	1958
Mr. Glenn C. David	Chief Financial Officer	N/A	N/A	1973
Ms. Judith A. Weinstein	Senior VP, General Counsel & Corporate Secretary	N/A	N/A	1969
Ms. Lisa A. Escudero	Senior Vice President of Human Resources	N/A	N/A	1962
Mr. Jonathan Bendheim	President of MACIE Region, GM of Israel Operations & Director	N/A	N/A	1976
Mr. Ramon Fuenmayor	President South America Region	N/A	N/A	N/A
Mr. Samson Li	President of Asia Pacific Region	N/A	N/A	1972

Amounts are as of 31 December 2023, and compensation values are for the last fiscal year ending on that date. Pay includes salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.

Description

Phibro Animal Health Corporation operates as an animal health and mineral nutrition company in the United States, Israel, Brazil, Ireland, and internationally. It operates through three segments: Animal Health, Mineral Nutrition, and Performance Products. The company develops, manufactures, and markets various products for food and companion animals including poultry, swine, beef and dairy cattle, aquaculture, and dogs. It also offers animal health products, such as antibacterials, anticoccidials, nutritional specialty, and vaccines and vaccine adjuvants for animal's health and performance, food safety, and animal welfare; and engages in development, manufacturing, and marketing of microbial and bioproducts for various applications serving animal health and nutrition, industrial, environmental, and agricultural customers. In addition, the company develops, manufactures, and markets conventionally licensed and autogenous vaccine products, as well as adjuvants for animal vaccine manufacturers. Further, it provides formulations and concentrations of trace minerals, such as zinc, manganese, copper, iron, and other compounds to fortify the daily feed requirements of their livestock's diets and maintain optimal balance of trace elements in animals. Additionally, the company offers specialty ingredients for personal care, industrial chemical, and chemical catalyst industries. It sells its animal health and mineral nutrition products through local sales offices to integrated poultry, swine, and cattle integrators, as well as through commercial animal feed manufacturers, wholesalers, and distributors. The company was formerly known as Philipp Brothers Chemicals, Inc. and changed its name to Phibro Animal Health Corporation in July 2003. Phibro Animal Health Corporation was founded in 1946 and is headquartered in Teaneck, New Jersey.

Corporate governance

Phibro Animal Health Corporation’s ISS governance QualityScore as of 1 April 2024 is 10. The pillar scores are Audit: 8; Board: 10; Shareholder rights: 10; Compensation: 6.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while 10 indicates higher governance risk.